
Navigating Second-Line RCC Treatment With Guidelines and Trial Data
Second-line treatment for clear cell renal cell carcinoma (RCC) remains challenging due to a lack of a preferred regimen and variable patient responses. During the virtual Case-Based Roundtable event, oncologists from the Southeastern United States …